A feasible and more efficient SARS-Cov-2 vaccine allocation to states and counties in the USA
View ORCID ProfileAnthony R. Ives, View ORCID ProfileClaudio Bozzuto
doi: https://doi.org/10.1101/2021.03.17.21253793
Anthony R. Ives
1Department of Integrative Biology, University of Wisconsin-Madison, Madison, WI 53706, USA.
Claudio Bozzuto
2Wildlife Analysis GmbH, Oetlisbergstrasse 38, 8053 Zurich, Switzerland.

Article usage
Posted March 17, 2021.
A feasible and more efficient SARS-Cov-2 vaccine allocation to states and counties in the USA
Anthony R. Ives, Claudio Bozzuto
medRxiv 2021.03.17.21253793; doi: https://doi.org/10.1101/2021.03.17.21253793
Subject Area
Subject Areas
- Addiction Medicine (269)
- Allergy and Immunology (549)
- Anesthesia (135)
- Cardiovascular Medicine (1749)
- Dermatology (172)
- Emergency Medicine (310)
- Epidemiology (10785)
- Gastroenterology (584)
- Genetic and Genomic Medicine (2935)
- Geriatric Medicine (286)
- Health Economics (531)
- Health Informatics (1919)
- Health Policy (833)
- Hematology (290)
- HIV/AIDS (627)
- Medical Education (299)
- Medical Ethics (86)
- Nephrology (323)
- Neurology (2786)
- Nursing (150)
- Nutrition (431)
- Oncology (1458)
- Ophthalmology (441)
- Orthopedics (172)
- Otolaryngology (255)
- Pain Medicine (190)
- Palliative Medicine (56)
- Pathology (380)
- Pediatrics (865)
- Primary Care Research (334)
- Public and Global Health (5342)
- Radiology and Imaging (1004)
- Respiratory Medicine (724)
- Rheumatology (329)
- Sports Medicine (278)
- Surgery (327)
- Toxicology (47)
- Transplantation (149)
- Urology (125)